Employment |
Company: Tempus |
Recipient: You |
Company: Aurora Health Care |
Recipient: You |
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
Company: Doximity |
Recipient: You |
Company: Tempus |
Recipient: You |
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Celgene |
Recipient: You |
Company: VIA Oncology |
Recipient: You |
Company: Takeda |
Recipient: You |
Company: Syapse Precision Medicine Council |
Recipient: You |
Company: Adaptive Biotechnologies |
Recipient: You |
Company: Epizyme |
Recipient: You |
Company: Janssen Oncology |
Recipient: You |
Company: Sanofi |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: Takeda |
Recipient: Your Institution |
Company: Bristol-Myers Squibb |
Recipient: Your Institution |
Company: TG Therapeutics |
Recipient: Your Institution |
Company: Abbvie |
Recipient: Your Institution |
Company: PrECOG |
Recipient: Your Institution |
Company: Strata Oncology |
Recipient: Your Institution |
Company: Lynx Biosciences |
Recipient: Your Institution |
Company: Denovo Biopharma |
Recipient: Your Institution |
Company: ARMO BioSciences |
Recipient: Your Institution |
Company: GSK |
Recipient: Your Institution |
Company: Amgen |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
Please describe: UpToDate, Peer Review for Plasma Cell Dyscrasias (Editor: Robert Kyle) |
Recipient: You |
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
Company: Doximity |
Recipient: You |
|
(OPTIONAL) Uncompensated Relationships |
No Relationships to Disclose |
|
|
(OPTIONAL) Open Payments Link |
|
Open Payments URL: https://openpaymentsdata.cms.gov/physician/192826/summary |
|